Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

540 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New Perspective in Cardiac Sarcoidosis: The Potential Role of a Dedicated Clinic and the Importance of Collaboration Among Different Specialties.
Lemay S, Beaudoin J, Philippon F, Rimac G, Lalancette JS, De Larochellière H, Gleeton G, Charbonneau É, Dion G, Trottier M, Albert A, Fortin S, Laliberté C, Komlosy MÈ, Toma M, Nery P, Birnie D, Sénéchal M. Lemay S, et al. Among authors: toma m. Can J Cardiol. 2023 Jul;39(7):981-984. doi: 10.1016/j.cjca.2023.04.007. Epub 2023 Apr 14. Can J Cardiol. 2023. PMID: 37062488 No abstract available.
Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT).
Birnie D, Beanlands RSB, Nery P, Aaron SD, Culver DA, DeKemp RA, Gula L, Ha A, Healey JS, Inoue Y, Judson MA, Juneau D, Kusano K, Quinn R, Rivard L, Toma M, Varnava A, Wells G, Wickremasinghe M, Kron J. Birnie D, et al. Among authors: toma m. Am Heart J. 2020 Feb;220:246-252. doi: 10.1016/j.ahj.2019.10.003. Epub 2019 Oct 20. Am Heart J. 2020. PMID: 31911261 Free PMC article.
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis.
O'Meara E, McDonald M, Chan M, Ducharme A, Ezekowitz JA, Giannetti N, Grzeslo A, Heckman GA, Howlett JG, Koshman SL, Lepage S, Mielniczuk LM, Moe GW, Swiggum E, Toma M, Virani SA, Zieroth S, De S, Matteau S, Parent MC, Asgar AW, Cohen G, Fine N, Davis M, Verma S, Cherney D, Abrams H, Al-Hesayen A, Cohen-Solal A, D'Astous M, Delgado DH, Desplantie O, Estrella-Holder E, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Lee D, Masoudi FA, McKelvie RS, Rajda M, Ross HJ, Sussex B. O'Meara E, et al. Among authors: toma m. Can J Cardiol. 2020 Feb;36(2):159-169. doi: 10.1016/j.cjca.2019.11.036. Can J Cardiol. 2020. PMID: 32036861
Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement on Heart Transplantation: Patient Eligibility, Selection, and Post-Transplantation Care.
Chih S, McDonald M, Dipchand A, Kim D, Ducharme A, Kaan A, Abbey S, Toma M, Anderson K, Davey R, Mielniczuk L, Campbell P, Zieroth S, Bourgault C, Badiwala M, Clarke B, Belanger E, Carrier M, Conway J, Doucette K, Giannetti N, Isaac D, MacArthur R, Senechal M. Chih S, et al. Among authors: toma m. Can J Cardiol. 2020 Mar;36(3):335-356. doi: 10.1016/j.cjca.2019.12.025. Can J Cardiol. 2020. PMID: 32145863
Review of eligibility for cardiac resynchronization therapy.
Hawkins NM, Bennett MT, Andrade JG, Virani SA, Krahn AD, Ignaszewski A, Toma M. Hawkins NM, et al. Among authors: toma m. Am J Cardiol. 2015 Jul 15;116(2):318-24. doi: 10.1016/j.amjcard.2015.04.026. Epub 2015 Apr 18. Am J Cardiol. 2015. PMID: 25975724 Review.
Should We Be Using Sex-Specific Heart Failure Risk Scores?
Diamant MJ, Toma M. Diamant MJ, et al. Among authors: toma m. Can J Cardiol. 2020 Jan;36(1):11-12. doi: 10.1016/j.cjca.2019.10.001. Epub 2019 Oct 8. Can J Cardiol. 2020. PMID: 31787437 No abstract available.
540 results